Pediatric Hematology and Oncology

(The TQCC of Pediatric Hematology and Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity20
Gut microbial composition difference between pediatric ALL survivors and siblings20
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas17
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial14
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India13
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study13
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas9
Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia9
COVID-19 reinfection in two children with cancer9
Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children9
Distinctive phenotypes in two children with novel germline RUNX1 mutations - one with myeloid malignancy and increased fetal hemoglobin8
Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma8
Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia8
Assessing the Relationship between PTSS in Childhood Cancer Survivors and Their Caregivers and Their Quality of Life7
Syrian and Turkish children with cancer: a comparison on survival and associated factors7
Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine7
Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21)7
Continuous deep sedation at the end of life in children with cancer: experience at a single center in Japan7
Challenges in the management of localized Ewing sarcoma in a developing country7
Association of body mass index with toxicity and survival in pediatric patients treated with cisplatin-containing regimens7
The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China6
Clinical variability in multifocal lymphangioendotheliomatosis with thrombocytopenia: a review of the literature6
The effect of cardiorespiratory fitness and physical activity levels on cognitive functions in survivors of childhood acute lymphoblastic leukemia6
High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies6
Caring for Children with Cancer in Africa during the COVID-19 Crisis: Implications and Opportunities6
Use of Tissue Plasminogen Activator as a Surrogate Measure for Central Venous Catheter Dysfunction and Survival Outcome in Children with Cancer: A Population-Based Retrospective Cohort Study6
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults6
Traumatic lumbar punctures in diagnostic and intrathecal treatment punctures of pediatric hemato-oncology patients6
Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium6
Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R45
Arsenic trioxide in pediatric cancer – a case series and review of literature5
Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study)5
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis5
Prevention and control strategies in the diagnosis and treatment of solid tumors in children during the COVID-19 pandemic5
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India5
Weight status and health behaviors of adolescents and young adults with sickle cell disease: The emerging risk for obesity5
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review5
Resilience in adolescents with thalassemia5
Application of the Scale for the Assessment and Rating of Ataxia (SARA) in pediatric oncology patients: A multicenter study5
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) – a case series5
Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta5
The announcement of treatment resistance from the pediatric oncologist’s point of view: a qualitative study5
Characteristics of parental decision-making for children with advanced cancer who are offered enrollment in early-phase clinical trials: A systematic review5
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients4
Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent4
Primary gastric lymphoma: A report of 16 pediatric cases treated at a single institute and review of the literature4
Spina bifida and pediatric cancers4
Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years4
Glucocorticoid resistance induced by ANXA5 overexpression in B-cell acute lymphoblastic leukemia4
Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia4
Clinical Characteristics and Outcomes of 101 Children with Hemophagocytic Lymphohistiocytosis: A Four-Year Single-Center Experience from Egypt4
Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer4
ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia4
Accuracy of online medical information: the case of social media in sickle cell disease4
Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report4
Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient4
Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania4
Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis4
Impact of the COVID-19 pandemic on health-related quality of life and anxiety in pediatric hematology/oncology patients4
Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma3
Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand3
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India3
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review3
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-23
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi3
Study of the diagnostic criteria for hemophagocytic lymphohistiocytosis in neonatal and pediatric patients with severe sepsis or septic shock3
Clinical value of RAG1 expression and IKZF1 deletions in Philadelphia negative pediatric B cell precursor acute lymphoblastic leukemia3
Seasonal variation of respiratory viral infections: a comparative study between children with cancer undergoing chemotherapy and children without cancer3
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia3
Usefulness of functional splicing analysis to confirm precise disease pathogenesis in Diamond-Blackfan anemia caused by intronic variants in RPS193
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative3
Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting3
Hereditary red blood cell membrane defects. Detection of PIEZO1 mutations associated with SPTA1 mutations. An unusual clinical case of hereditary xerocytosis3
Heart rate response and chronotropic incompetence during cardiopulmonary exercise testing in childhood acute lymphoblastic leukemia survivors3
Retrospective analysis of predisposing factors for difficult lumbar punctures requiring image guidance in pediatric oncology patients3
Outcome and complications of pediatric acute promyelocytic leukemia in Bangladesh3
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China3
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study3
Low expression of CTBP2 and CASP8AP2 predicts risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a retrospective cohort study3
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers3
Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience3
Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group3
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis3
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report3
Nutritional status as a predictor of adverse events and survival in pediatric autologous stem cell transplant3
Fertility preservation education for pediatric hematology-oncology fellows, faculty and advanced practice providers: a pilot study3